Terlipressin

Раствор By prescription

Terlipressin is a synthetic analogue of vasopressin (hormone of the posterior lobe of the pituitary gland), it has a pronounced vasoconstrictive and styptic effect.

Terlipressin

Indications

The drug Terlipressin is indicated for use in adults with:

- bleeding from the gastrointestinal tract (GIT) and genital organs: in oesophageal varices, gastric and duodenal ulcers;

- uterine bleeding (dysfunctional, in labour and at termination of pregnancy);

- gynaecological operations on the cervix (local administration);

- bleeding during surgery on the abdominal cavity and pelvic organs;

- hepatorenal syndrome type I (rapidly progressive renal failure).

Contraindications

Do not use the preparation Terlipressin:

- if you are allergic to terlipressin or any other components of the drug (listed in section 6);

- if you have septic shock (severe generalised infection) with low cardiac output.

Usage

Terlipressin is intended for intravenous administration as bolus injections or short-term infusion, as well as for para- and/or intracervical administration during gynaecological operations on the cervix.

Download full instruction

Report undesirable reaction

If you have information about undesirable reaction after taking the drug

Hotline +7 (495) 984-28-47

Report

Have questions? Contact Us

Has contraindications. Needs specialist overview.

Please read our privacy policy

The present personal data processing policy is drawn up in accordance with the requirements of the Federal Law of July 27, 2006. No. 152-FЗ “On Personal Data” and determines the procedure for processing personal data and measures to ensure the security of personal data of Mir-Pharm LLC (hereinafter referred to as the Operator).

The operator sets as his most important goal and condition for the implementation of his activities the respect for the rights and freedoms of man and citizen in the processing of his personal data, including the protection of the rights to privacy, personal and family confidentiality.

The Operator's policy regarding the processing of personal data (hereinafter - the Policy) applies to all information that the Operator can receive about visitors of the website https://mirpharm.ru.

The user can get any clarification on issues of interest regarding the processing of his personal data by contacting the Operator via e-mail info@mirpharm.ru.

The current version of the Policy is located in free access on the Internet at https://mirpharm.ru/policy.

This document will reflect any changes in the policy of processing personal data by the Operator. The policy is valid indefinitely until it is replaced with a new version.